![]() |
|
|
|
|
![]() |
Home | ![]() |
![]() |
Complementary Medicine |
![]() |
![]() |
Conditions | ![]() |
Family Health |
![]() |
![]() |
Legalities & Informatics |
![]() |
![]() |
News
& Updates |
![]() |
![]() |
Health Resources |
![]() |
![]() |
Support Groups |
![]() |
||||||||||||||||
![]() |
||||||||||||||||||||
Home > Conditions & Concerns > Communicable Diseases > AIDS > Treatment |
||
|
|
Treatment |
|
|
|
Saquinavir, manufactured under the trade name Invirase, has recently been approved by the FDA for use in the treatment of AIDS. It is the first to be approved in a new group of drugs claimed to be 10 times stronger than existing anti-virals used in AIDS treatment. |
|
Highlights |
|
Related Issues |
|
( Treatment ) |
|
Other anti-viral agents are in investigational stages. Hematopoietic stimulating factors are sometimes used to treat anemia and low white blood cell counts associated with AIDS. NOTE: ELISA/RAPID test for HIV diagnosis is being carried out in many Centres all over the country. Further, all Microbiology departments in Government medical colleges will be providing HIV testing facilities and will be known as Voluntary Blood Testing Centres. Clinical goals Prolongation of life and improved quality of life. Virological goals Reduction in viral load as much as possible (<20 c/ml) for as long as possible to:
Immunological goals Achieve immune reconstitution that is antitative (CD-4 count in normal range) and qualitative (pathogen-specific immune response) Therapeutic goals Rational sequencing of drugs in a fashion that achieves virological goals, but also:
Epidemiological goals Reduce HIV transmission
|
||||||||||
| |||||||||